Latest Insights on GM
Profit From AbbVie’s Struggles Today
February 4, 2020 American Investor Today, Stocks
Abbvie’s flagship medication Humira is a huge seller in the U.S. and abroad. But as more companies develop their own versions, will Abbvie’s stock crater in the face of tighter competition? I’ll review Abbvie’s balance sheet and fundamentals to let you know whether you should expect the stock to surge — or fall even further in 2020. No Fear Here: 4 Stocks to Beat the Wuhan Virus
January 31, 2020 2020 Financial Crisis, Great Stuff
Friday Four Play: The “Fear Inoculum” Edition (Did a friend forward you this email? If so, you owe them big-time! Seriously, this is Great Stuff. We don’t take that title lightly. After you’ve thanked your friend profusely, why not sign up for yourself today? It’s mostly painless. I promise.) The Wuhan coronavirus is officially a […] Self-Driving Cars Are Coming: Invest Now for Huge Profits
January 31, 2020 Investment Opportunities, Technology, Winning Investor Daily
Goldman Sachs believes self-driving cars will be a $7 trillion market. And that massive disruption is closer than most expect… Tesla’s Cash Flows; Verizon’s Crossroads; Facebook Erodes
January 30, 2020 Great Stuff
Tesla to Bears: Eat My Shorts Do we have any Tesla Inc. (Nasdaq: TSLA) bears reading today? I know you’re out there. You write in to Great Stuff every time I say something positive about the company. Well, get your emails ready. Today, Tesla’s taking a victory lap … and I’m saying: “I told you […] Kung Flu Crazy; Borg Assimilates Delphi; Apple Cooks up Earnings
January 28, 2020 Great Stuff
Kung Flu Crazy Another day, another virus story. Are you sick and tired of the “kung flu” yet? (Editor’s Note: If you’re sick and tired with the kung flu, please seek medical attention immediately.) After getting the sweats yesterday, the market appears to feel much better today. Much like you when you’re out of sick […]